Application of Ranolazine in Stable Angina Pectoris Therapy (ARETHA): Real-World Data from an Observational Study
نویسندگان
چکیده
Holger Diedrichs*1, Ulrike Wollenberg2, Kristin Schmerbach2, Roger Limberg2, Guido Schiffhorst3, Andreas Michael Zeiher4 1Herzzentrum, Uniklinik Köln, Kerpener Straße 62, 50937, Cologne, Germany 2Berlin-Chemie AG, Glienicker Weg 125, 124 Berlin, Berlin, Germany 3IGES Institut GmbH, Friedrichstraße 180, 10117 Berlin, Berlin, Germany 4Klinikum der Johann-Wolfgang Goethe-Universität, Medizinische Klinik III
منابع مشابه
Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris
Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. The aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. Materials and Methods: A prospective clinical s...
متن کاملRanolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
BACKGROUND To conduct an economic evaluation comparing ranolazine as add-on therapy to standard-of-care (SoC) with SoC alone in patients with stable angina who did not respond adequately to first line therapy, in Greece. METHODS A decision tree model was locally adapted in the Greek setting to evaluate the cost-utility of ranolazine during a 6-month period. The analysis was conducted from a t...
متن کاملImprovement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
INTRODUCTION We aimed to assess if ranolazine would improve angina symptoms among patients with documented myocardial ischemia. METHODS Eligible subjects had chronic stable angina and at least one coronary stenosis with fractional flow reserve (FFR) ≤0.80 or at least one chronic total occlusion (CTO) without attempted revascularization. Subjects were randomized to oral ranolazine 500 mg twice...
متن کاملPlacebo in Patients With Chronic Stable Angina Pectoris
Background Ranolazine modulates the metabolism of ischemic myocardial cells and improves the efficiency of oxygen use. This study was conducted to evaluate the antianginal and anti-ischemic effects and safety of different doses of ranolazine administered three times daily (tid) compared with placebo in patients with stable angina pectoris. Methods and Results Patients with stable angina pectori...
متن کاملNovel Anti-Ischemic Agent, Ranolazine, Versus Placebo in Patients With Chronic Stable Angina Pectoris
Background Ranolazine modulates the metabolism of ischemic myocardial cells and improves the efficiency of oxygen use. This study was conducted to evaluate the antianginal and anti-ischemic effects and safety of different doses of ranolazine administered three times daily (tid) compared with placebo in patients with stable angina pectoris. Methods and Results Patients with stable angina pectori...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016